|
 |
DynacinThis page contains recent news articles, when available, and an overview of Dynacin but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: Dynacin (when available) Minocycline, the most lipid soluble and most active tetracycline antibiotic, is, like doxycycline, a long-acting tetracycline. Minocycline's effects are related to the inhibition of protein synthesis. Minocycline is used to treat nongonococcal urethritis, mucopurulent cervicitis, acne vulgaris, and rheumatoid arthritis and some othet infections. Because of its lipid solubility, minocycline is able to eradicate the meningococcal carrier state in tears and saliva. For the treatment of infections caused by susceptible strains of microorganisms, such as Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by Rickettsiae, Upper respiratory tract infections caused by Streptococcus pneumoniee; For the treatment of asymptomatic carriers of Neisseria meningitidis Mechanism Of Action: Minocycline passes directly through the lipid bilayer or passively diffuses through porin channels in the bacterial membrane. Tetracyclines like minocycline bind to the 30 S ribosomal subunit, preventing the binding of tRNA to the mRNA-ribosome complex and interfering with protein synthesis. News Articles on Minocycline Medicis Reports Third Quarter 2009 Financial Results - Nov 4, 2009 The Company's products include the brands DYSPORT(TM) (abobotulinumtoxinA) 300 Units for Injection, PERLANE(R), RESTYLANE(R), DYNACIN(R) (minocycline HCl ... CNNMoney.com (press release) Medicis Announces Third Quarter 2009 Conference Call and Webcast - Nov 2, 2009 The Company's products include the brands DYSPORT(TM) (abobotulinumtoxinA) 300 Units for Injection, PERLANE(R), RESTYLANE(R), DYNACIN(R) (minocycline HCl ... Reuters Medicis Pharmaceutical Corporation - Pharmaceuticals & Healthcare - Deals and ... - Nov 9, 2009 The company´s branded products for various therapeutic categories include, Dynacin, Loprox, Plexion, Solodyn, Triaz, Vanos and Ziana, Ammonul, Buphenyl, ... PR-Inside.com (Pressemitteilung) Medicis Reports Second Quarter 2009 Financial Results - Aug 5, 2009 The Company's products include the brands DYSPORT(TM) (abobotulinumtoxinA), PERLANE(R) (hyaluronic acid), RESTYLANE(R) (hyaluronic acid), DYNACIN(R) FOXBusiness BUYINS.NET: KTC, GG, PCBC, MRX, AET, CACI Are Seasonally Biased To ... - Jul 2, 2009 Its products include DYNACIN for the treatment of acne and acne-related dermatological conditions; PLEXION, a cleanser product; SOLODYN for the treatment of TMC Net Medicis Announces New Notice of Allowance for SOLODYN(R) 90mg - Apr 17, 2009 The Company's products include the brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox) GlobeNewsWire (press release) BUYINS.NET: Market Maker Surveillance Report. Top 6 Abnormal Price ... - 18 Mar 2009 Its products include DYNACIN for the treatment of acne and acne-related dermatological conditions; PLEXION, a cleanser product; SOLODYN for the treatment of Trading Markets (press release) Medicis Announces 2008 Fourth Quarter and Year-End Conference Call ... - Feb 23, 2009 The Company's products include the brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), LOPROX(R) (ciclopirox) MSNBC Medicis to Present At JP Morgan Healthcare Conference - Jan 8, 2009 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), MSNBC Medicis to Present At RBC Capital Markets Healthcare Conference - Dec 8, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), MarketWatch Medicis and IMPAX Announce R&D Collaboration and Settlement - Dec 1, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), MarketWatch Medicis Pharmaceutical Corporation - Premium Company Profile - New ... - Nov 14, 2008 In the dermatological field it offers products such as Dynacin, Plexion, Solodyn, Triaz and Ziana for the treatment of acne and acne-related dermatological Live-PR.com (Pressemitteilung), Medicis Announces Third Quarter 2008 Conference Call and Webcast - Nov 6, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), MarketWatch Annual Report to shareholders - Oct 19, 2008 It is marketed under several trade names, including Minomycin, Minocin, Arestin, and Dynacin. Minocycline formulations are the largest selling tetracycline Sydney Morning Herald, Medicis Announces FDA Approval of PMA Supplement for RESTYLANE - Oct 10, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), Trading Markets (press release), From Site Selection magazine, September 2008 - Oct 6, 2008 Medicis also markets a variety of dermatological pharmaceuticals, including Dynacin, which is used to treat acne. A new facility in Tucson will help solve Site Selection, Medicis Announces Intent to Restate Financial Statements - Sep 24, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), GlobeNewsWire (press release), Medicis to Present At Thomas Weisel Partners Healthcare Conference ... - Sep 2, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), GlobeNewsWire (press release), Medicis Reports Second Quarter 2008 Financial Results - Aug 5, 2008 Medicis' acne products include primarily DYNACIN(R), PLEXION(R), SOLODYN(R), TRIAZ(R) and ZIANA(R). Medicis recorded revenues of approximately $40.9 million MarketWatch Medicis Announces Second Quarter 2008 Conference Call and Webcast - Jul 31, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), MarketWatch Medicis to Acquire LipoSonix - Jun 16, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), Primenewswire (press release), Medicis to Present At Goldman Sachs Global Healthcare Conference - Jun 6, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), CNNMoney.com (press release) Medicis Announces First Quarter 2008 Conference Call and Webcast - May 6, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), FOXBusiness Ipsen and Medicis Announce Acceptance of Reloxin(R) BLA in ... - May 18, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), PR-Inside.com (Pressemitteilung), Medicis Announces the Early Adoption of Online Proxy Materials for ... - Apr 8, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), Primenewswire (press release), Senetek PLC Announces Riley-Nacht LLC - Leading Global Brand ... - Apr 17, 2008 Mr. Riley was also involved in the launch and/or marketing of the Medicis prescription and OTC products, including Lustra(R), Esoterica(R), Dynacin(R), PR Newswire (press release), Medicis Reports Fourth Quarter and Year End 2007 Financial Results - Feb 28, 2008 The Company's products include the prescription brands RESTYLANE(R) (hyaluronic acid), PERLANE(R) (hyaluronic acid), DYNACIN(R) (minocycline HCl), FOXBusiness Brand Names/Synonyms: Dynacin is also known by the following brand names and/or synonyms: Alti-Minocycline; Apo-Minocycline; Arestin; BRN 3077644; CL 59806; DYNACIN; Dynacin; Gen-Minocycline; HSDB 3130; Klinomycin; MINOCYCLINE; Minociclina [Inn-Spanish]; Minocin; Minocyclin; Minocycline; Minocycline Hcl; Minocycline [Usan:Ban:Inn]; Minocyclinum [Inn-Latin]; Minocyn; Minomycin; Novo-Minocycline; Vectrin Drug Category: Dynacin is categorized under the following by the FDA: Anti-bacterial Agents; Tetracyclines; ATC:A01AB23; ATC:J01AA08 Dosage Forms: Capsules; Subgingival (sustained-release); IV Injection; Absorption: rapidly absorbed from the gastrointestinal tract Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 2-(amino-hydroxy-methylidene)-4,7-bis(dimethylamino)-10,11,12a-trihydroxy-4,4a,5,5a,6,12a-hexahydrotetracene-1,3,12-trione |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
